163 related articles for article (PubMed ID: 17891780)
1. DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells.
Sundaram K; Mani SK; Kitatani K; Wu K; Pestell RG; Reddy SV
J Cell Biochem; 2008 Apr; 103(6):1747-59. PubMed ID: 17891780
[TBL] [Abstract][Full Text] [Related]
2. Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells.
Roccisana JL; Kawanabe N; Kajiya H; Koide M; Roodman GD; Reddy SV
J Biol Chem; 2004 Mar; 279(11):10500-7. PubMed ID: 14699143
[TBL] [Abstract][Full Text] [Related]
3. RANK ligand expression in heat shock factor-2 deficient mouse bone marrow stromal/preosteoblast cells.
Kajiya H; Ito M; Ohshima H; Kenmotsu S; Ries WL; Benjamin IJ; Reddy SV
J Cell Biochem; 2006 Apr; 97(6):1362-9. PubMed ID: 16365894
[TBL] [Abstract][Full Text] [Related]
4. FGF-2 stimulation of RANK ligand expression in Paget's disease of bone.
Sundaram K; Senn J; Yuvaraj S; Rao DS; Reddy SV
Mol Endocrinol; 2009 Sep; 23(9):1445-54. PubMed ID: 19556344
[TBL] [Abstract][Full Text] [Related]
5. SOCS-1/3 participation in FGF-2 signaling to modulate RANK ligand expression in paget's disease of bone.
Sundaram K; Senn J; Reddy SV
J Cell Biochem; 2013 Sep; 114(9):2032-8. PubMed ID: 23553658
[TBL] [Abstract][Full Text] [Related]
6. STAT-6 mediates TRAIL induced RANK ligand expression in stromal/preosteoblast cells.
Sundaram K; Sambandam Y; Balasubramanian S; Pillai B; Voelkel-Johnson C; Ries WL; Reddy SV
Bone; 2015 Feb; 71():137-44. PubMed ID: 25445452
[TBL] [Abstract][Full Text] [Related]
7. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
Liu J; Yang H; Liu W; Cao X; Feng X
J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.
Shin CS; Her SJ; Kim JA; Kim DH; Kim SW; Kim SY; Kim HS; Park KH; Kim JG; Kitazawa R; Cheng SL; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2200-12. PubMed ID: 16294273
[TBL] [Abstract][Full Text] [Related]
9. CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.
Sambandam Y; Sundaram K; Liu A; Kirkwood KL; Ries WL; Reddy SV
Oncogene; 2013 Jan; 32(1):97-105. PubMed ID: 22330139
[TBL] [Abstract][Full Text] [Related]
10. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
Takami M; Takahashi N; Udagawa N; Miyaura C; Suda K; Woo JT; Martin TJ; Nagai K; Suda T
Endocrinology; 2000 Dec; 141(12):4711-9. PubMed ID: 11108286
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K
Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755
[TBL] [Abstract][Full Text] [Related]
12. The increased expression of receptor activator of nuclear-kappaB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate.
Fernández M; Pino AM; Figueroa P; Rodríguez JP
J Cell Biochem; 2010 Sep; 111(1):130-7. PubMed ID: 20506157
[TBL] [Abstract][Full Text] [Related]
13. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
14. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44.
Cao JJ; Singleton PA; Majumdar S; Boudignon B; Burghardt A; Kurimoto P; Wronski TJ; Bourguignon LY; Halloran BP
J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667
[TBL] [Abstract][Full Text] [Related]
16. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic control of mouse receptor activator of NF-kappa B ligand gene expression.
Kitazawa S; Kitazawa R
Biochem Biophys Res Commun; 2002 Apr; 293(1):126-31. PubMed ID: 12054573
[TBL] [Abstract][Full Text] [Related]
18. Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell- and tissue-specific RANKL expression and osteoclastogenesis.
Kitazawa R; Kitazawa S
Mol Endocrinol; 2007 Jan; 21(1):148-58. PubMed ID: 17008384
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
20. Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors.
Singh PP; van der Kraan AG; Xu J; Gillespie MT; Quinn JM
Biochem Biophys Res Commun; 2012 May; 422(1):48-53. PubMed ID: 22561018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
